AMI Asset Management Corp Has $3.60 Million Stock Holdings in Itron, Inc. (NASDAQ:ITRI)

AMI Asset Management Corp lessened its stake in Itron, Inc. (NASDAQ:ITRI) by 36.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 38,870 shares of the scientific and technical instruments company’s stock after selling 22,573 shares during the quarter. AMI Asset Management Corp owned 0.08% of Itron worth $3,596,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Trexquant Investment LP increased its stake in Itron by 18.4% in the 4th quarter. Trexquant Investment LP now owns 67,973 shares of the scientific and technical instruments company’s stock valued at $5,133,000 after buying an additional 10,542 shares during the period. Los Angeles Capital Management LLC acquired a new position in shares of Itron during the 1st quarter worth $2,002,000. Vanguard Group Inc. increased its stake in shares of Itron by 2.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,668,071 shares of the scientific and technical instruments company’s stock worth $343,372,000 after purchasing an additional 142,564 shares during the last quarter. Oppenheimer & Co. Inc. increased its stake in shares of Itron by 91.1% during the 4th quarter. Oppenheimer & Co. Inc. now owns 30,568 shares of the scientific and technical instruments company’s stock worth $2,308,000 after purchasing an additional 14,573 shares during the last quarter. Finally, S&CO Inc. acquired a new position in shares of Itron during the 4th quarter worth $249,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Transactions at Itron

In other news, SVP Christopher E. Ware sold 311 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $106.84, for a total transaction of $33,227.24. Following the completion of the transaction, the senior vice president now directly owns 15,371 shares of the company’s stock, valued at approximately $1,642,237.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Thomas Deitrich sold 873 shares of Itron stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $108.87, for a total transaction of $95,043.51. Following the completion of the transaction, the chief executive officer now directly owns 206,163 shares of the company’s stock, valued at approximately $22,444,965.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher E. Ware sold 311 shares of Itron stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $106.84, for a total transaction of $33,227.24. Following the transaction, the senior vice president now directly owns 15,371 shares of the company’s stock, valued at $1,642,237.64. The disclosure for this sale can be found here. In the last three months, insiders sold 1,775 shares of company stock valued at $192,613. Company insiders own 1.45% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. JPMorgan Chase & Co. increased their price target on shares of Itron from $77.00 to $92.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. Piper Sandler lowered shares of Itron from an “overweight” rating to a “neutral” rating and set a $109.00 price target on the stock. in a research note on Tuesday, May 21st. Robert W. Baird increased their price target on shares of Itron from $108.00 to $115.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 13th. StockNews.com lowered shares of Itron from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 28th. Finally, TD Cowen raised their target price on shares of Itron from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $104.64.

Itron Stock Performance

Itron stock traded up $0.68 during mid-day trading on Thursday, reaching $99.47. The company had a trading volume of 145,766 shares, compared to its average volume of 790,720. The company has a 50 day moving average of $104.14 and a 200-day moving average of $89.72. The firm has a market cap of $4.56 billion, a price-to-earnings ratio of 28.58, a PEG ratio of 0.95 and a beta of 1.45. Itron, Inc. has a 52 week low of $56.11 and a 52 week high of $111.00. The company has a quick ratio of 1.40, a current ratio of 1.90 and a debt-to-equity ratio of 0.33.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. The company had revenue of $603.44 million during the quarter, compared to the consensus estimate of $579.49 million. Itron had a net margin of 7.03% and a return on equity of 14.51%. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS. On average, sell-side analysts expect that Itron, Inc. will post 4 EPS for the current fiscal year.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.